Ketoconazole in vitro inhibits mitogen-induced blastogenesis, antibody-dependent cellular cytotoxicity, natural killer activity and random migration of human leukocytes

Immunopharmacology. 1984 Jun;7(3-4):167-70. doi: 10.1016/0162-3109(84)90033-x.

Abstract

Ketoconazole at concentrations of 1-10 micrograms/ml dose dependently inhibits mitogen-induced blastogenesis, antibody-dependent and spontaneous cytotoxic (natural killer) activity of human lymphocytes and random migration of human leukocytes. Lectin-dependent cytotoxic activity is not affected by the drug.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibody-Dependent Cell Cytotoxicity / drug effects*
  • Cell Migration Inhibition
  • Cells, Cultured
  • Cytotoxicity Tests, Immunologic
  • Humans
  • Ketoconazole / pharmacology*
  • Killer Cells, Natural / immunology*
  • Leukocytes / immunology*
  • Lymphocyte Activation / drug effects
  • Lymphocytes / immunology*
  • Phytohemagglutinins / pharmacology

Substances

  • Phytohemagglutinins
  • Ketoconazole